Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.11
MLAB's Cash to Debt is ranked lower than
52% of the 307 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. MLAB: 0.11 )
MLAB' s 10-Year Cash to Debt Range
Min: 0.11   Max: No Debt
Current: 0.11

Equity to Asset 0.60
MLAB's Equity to Asset is ranked higher than
70% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. MLAB: 0.60 )
MLAB' s 10-Year Equity to Asset Range
Min: 0.6   Max: 0.97
Current: 0.6

0.6
0.97
F-Score: 5
Z-Score: 5.18
M-Score: -3.14
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 22.35
MLAB's Operating margin (%) is ranked higher than
92% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.05 vs. MLAB: 22.35 )
MLAB' s 10-Year Operating margin (%) Range
Min: 22.35   Max: 38.27
Current: 22.35

22.35
38.27
Net-margin (%) 17.07
MLAB's Net-margin (%) is ranked higher than
90% of the 292 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.65 vs. MLAB: 17.07 )
MLAB' s 10-Year Net-margin (%) Range
Min: 17.07   Max: 25.93
Current: 17.07

17.07
25.93
ROE (%) 13.99
MLAB's ROE (%) is ranked higher than
88% of the 289 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. MLAB: 13.99 )
MLAB' s 10-Year ROE (%) Range
Min: 13.85   Max: 20
Current: 13.99

13.85
20
ROA (%) 9.23
MLAB's ROA (%) is ranked higher than
88% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.19 vs. MLAB: 9.23 )
MLAB' s 10-Year ROA (%) Range
Min: 9.23   Max: 18.18
Current: 9.23

9.23
18.18
ROC (Joel Greenblatt) (%) 63.85
MLAB's ROC (Joel Greenblatt) (%) is ranked higher than
94% of the 295 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.08 vs. MLAB: 63.85 )
MLAB' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 42.25   Max: 83.32
Current: 63.85

42.25
83.32
Revenue Growth (%) 12.40
MLAB's Revenue Growth (%) is ranked higher than
88% of the 274 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. MLAB: 12.40 )
MLAB' s 10-Year Revenue Growth (%) Range
Min: 1.2   Max: 24.7
Current: 12.4

1.2
24.7
EBITDA Growth (%) 7.10
MLAB's EBITDA Growth (%) is ranked higher than
74% of the 237 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.90 vs. MLAB: 7.10 )
MLAB' s 10-Year EBITDA Growth (%) Range
Min: 4.1   Max: 27.8
Current: 7.1

4.1
27.8
EPS Growth (%) 10.20
MLAB's EPS Growth (%) is ranked higher than
78% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.80 vs. MLAB: 10.20 )
MLAB' s 10-Year EPS Growth (%) Range
Min: 0.7   Max: 24
Current: 10.2

0.7
24
» MLAB's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MLAB Guru Trades in Q3 2013

Chuck Royce 81,389 sh (+58.38%)
Jim Simons 111,200 sh (+24.66%)
» More
Q4 2013

MLAB Guru Trades in Q4 2013

Jim Simons 126,188 sh (+13.48%)
Chuck Royce 82,089 sh (+0.86%)
» More
Q1 2014

MLAB Guru Trades in Q1 2014

Jim Simons 134,143 sh (+6.3%)
Chuck Royce 54,519 sh (-33.59%)
» More
Q2 2014

MLAB Guru Trades in Q2 2014

Jim Simons 160,600 sh (+19.72%)
Chuck Royce 52,589 sh (-3.54%)
» More
» Details

Insider Trades

Latest Guru Trades with MLAB

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.20
MLAB's P/E(ttm) is ranked higher than
70% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.90 vs. MLAB: 28.20 )
MLAB' s 10-Year P/E(ttm) Range
Min: 10.38   Max: 42.36
Current: 28.2

10.38
42.36
P/B 3.90
MLAB's P/B is ranked higher than
52% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.02 vs. MLAB: 3.90 )
MLAB' s 10-Year P/B Range
Min: 1.61   Max: 5.5
Current: 3.9

1.61
5.5
P/S 4.40
MLAB's P/S is ranked lower than
64% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.91 vs. MLAB: 4.40 )
MLAB' s 10-Year P/S Range
Min: 2.32   Max: 6.86
Current: 4.4

2.32
6.86
PFCF 27.00
MLAB's PFCF is ranked higher than
76% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 65.30 vs. MLAB: 27.00 )
MLAB' s 10-Year PFCF Range
Min: 8.29   Max: 37.1
Current: 27

8.29
37.1
EV-to-EBIT 22.35
MLAB's EV-to-EBIT is ranked higher than
76% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 22.59 vs. MLAB: 22.35 )
MLAB' s 10-Year EV-to-EBIT Range
Min: 5.3   Max: 30.3
Current: 22.35

5.3
30.3
PEG 2.00
MLAB's PEG is ranked higher than
89% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MLAB: 2.00 )
MLAB' s 10-Year PEG Range
Min: 0.43   Max: 3.76
Current: 2

0.43
3.76
Shiller P/E 32.60
MLAB's Shiller P/E is ranked higher than
76% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MLAB: 32.60 )
MLAB' s 10-Year Shiller P/E Range
Min: 13.49   Max: 48.12
Current: 32.6

13.49
48.12
Current Ratio 2.26
MLAB's Current Ratio is ranked higher than
66% of the 223 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.00 vs. MLAB: 2.26 )
MLAB' s 10-Year Current Ratio Range
Min: 1.67   Max: 20.29
Current: 2.26

1.67
20.29
Quick Ratio 1.46
MLAB's Quick Ratio is ranked higher than
66% of the 223 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.09 vs. MLAB: 1.46 )
MLAB' s 10-Year Quick Ratio Range
Min: 0.96   Max: 16
Current: 1.46

0.96
16

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
MLAB's Dividend Yield is ranked lower than
66% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.37 vs. MLAB: 0.80 )
MLAB' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.6
Current: 0.8

0.5
2.6
Dividend Payout 0.24
MLAB's Dividend Payout is ranked higher than
90% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MLAB: 0.24 )
MLAB' s 10-Year Dividend Payout Range
Min: 0.16   Max: 0.35
Current: 0.24

0.16
0.35
Dividend growth (3y) 8.00
MLAB's Dividend growth (3y) is ranked higher than
78% of the 114 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.00 vs. MLAB: 8.00 )
MLAB' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 44.2
Current: 8

0
44.2
Yield on cost (5-Year) 1.20
MLAB's Yield on cost (5-Year) is ranked lower than
54% of the 176 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.40 vs. MLAB: 1.20 )
MLAB' s 10-Year Yield on cost (5-Year) Range
Min: 0.75   Max: 3.89
Current: 1.2

0.75
3.89
Share Buyback Rate -2.70
MLAB's Share Buyback Rate is ranked higher than
74% of the 236 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.20 vs. MLAB: -2.70 )
MLAB' s 10-Year Share Buyback Rate Range
Min: 6.1   Max: -2.9
Current: -2.7

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.40
MLAB's Price/DCF (Projected) is ranked higher than
80% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. MLAB: 1.40 )
MLAB' s 10-Year Price/DCF (Projected) Range
Min: 0.51   Max: 1.85
Current: 1.4

0.51
1.85
Price/Median PS Value 1.20
MLAB's Price/Median PS Value is ranked higher than
56% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.10 vs. MLAB: 1.20 )
MLAB' s 10-Year Price/Median PS Value Range
Min: 0.42   Max: 1.63
Current: 1.2

0.42
1.63
Price/Peter Lynch Fair Value 1.90
MLAB's Price/Peter Lynch Fair Value is ranked higher than
87% of the 320 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. MLAB: 1.90 )
MLAB' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.45   Max: 3.49
Current: 1.9

0.45
3.49
Earnings Yield (Greenblatt) 4.60
MLAB's Earnings Yield (Greenblatt) is ranked higher than
60% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. MLAB: 4.60 )
MLAB' s 10-Year Earnings Yield (Greenblatt) Range
Min: 3.3   Max: 18.7
Current: 4.6

3.3
18.7
Forward Rate of Return (Yacktman) 17.62
MLAB's Forward Rate of Return (Yacktman) is ranked higher than
91% of the 259 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.15 vs. MLAB: 17.62 )
MLAB' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 8.4   Max: 30.1
Current: 17.62

8.4
30.1

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Mesa Laboratories, Inc. was incorporated under the laws of the State of Colorado on March 26, 1982. It is organized into two divisions across four physical locations. The Instruments Division designs, manufactures and markets quality control instruments and disposable products utilized in connection with the healthcare, pharmaceutical, food and beverage, medical device, industrial hygiene, semiconductor and petrochemical industries. The Biological Indicators Division manufactures and markets biological indicators and distributes chemical indicators used to assess the effectiveness of sterilization processes, including steam, gas, hydrogen peroxide and radiation, in the hospital, dental, medical device and pharmaceutical industries. Its Lakewood, Colorado and Butler, New Jersey facilities manufacture its Instruments Division products, which include the DataTrace, Medical, Bios, Torqo, and Nusonics brands. Its Omaha, Nebraska and Bozeman, Montana locations manufacture its Biological Indicators Division products — the Mesa and Apex brands. The Company's revenues come from two main sources — product sales, and parts and services. Its Instruments Division products include: DataTrace data loggers, which are used in critical manufacturing and quality control processes in the food, pharmaceutical and medical device industries; Medical meters and calibration solutions, which are used for quality control in dialysis clinics and dialysis machine manufacturing operations; Gas flow calibration equipment, which is used for quality control, occupational health and safety, and environmental air monitoring in metrology labs, industrial hygiene and environmental air sampling; Torqo torque testing systems, which are used to measure bottle cap tightness in the beverage and pharmaceutical industries; and Nusonics concentration analyzers, pipeline interface detectors and flow meter products used in the chemical, food, pharmaceutical and plastics industries. Biological indicators consist of resistant spores of certain microorganisms that are applied on a convenient substrate, such as a small piece of filter paper. The spores are well characterized in terms of numbers and resistance to sterilization. In use, the biological indicator is exposed to a sterilization process and then tested to determine the presence of surviving organisms. Its biological indicators include spore strips, which require post-processing transfer to a growth media, self-contained products, which have the growth media already pre-packaged in crushable ampoules, and culture media. Chemical indicators are similar to biological indicators, except that a chemical change (generally determined by color) is used to assess the exposure to sterilization conditions. Biological indicators and chemical indicators are often used together to monitor processes. Biological indicators are used to validate equipment and monitor the effectiveness of a process in any industrial or healthcare sett
» More Articles for MLAB

Headlines

Articles On GuruFocus.com
Mesa Laboratories Inc. (MLAB) CFO, Secretary Steven W Peterson sells 10,000 Shares Mar 03 2011 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 15 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 16 2010 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Nov 16 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Aug 14 2009 
Mesa Labs Reports Higher First Quarter Earnings Aug 11 2009 
Mesa Laboratories Inc. Reports Operating Results (10-Q) Feb 13 2009 
Mesa Labs Reports Higher Quarterly Sales and Earnings Feb 10 2009 

More From Other Websites
MESA LABORATORIES INC /CO Financials Aug 15 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
Mesa Labs Reports 46% Increase in First Quarter Revenues Aug 06 2014
Who is Mesa Labs? Aug 04 2014
Mesa Labs Declares Quarterly Dividend Jul 22 2014
Mesa Labs Declares Quarterly Dividend Jul 17 2014
MESA LABORATORIES INC /CO Files SEC form 10-K, Annual Report Jun 04 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Jun 02 2014
Mesa Labs Reports Record Net Income and Revenues Jun 02 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation... Apr 15 2014
Mesa Labs acquires BGI Instruments business for $9.9M Apr 15 2014
Mesa Laboratories: A Highly Overvalued Levered Rollup With Low Single-Digit Organic Growth And... Apr 12 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events Apr 07 2014
MESA LABORATORIES INC /CO Files SEC form 10-Q, Quarterly Report Feb 05 2014
Mesa Labs Reports Record Quarterly Revenues Feb 04 2014
U.S./Canada daily earnings hits & misses Feb 3 - 1800 ET Feb 03 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Results of Operations and Financial Condition Feb 03 2014
Mesa Labs Reports Record Quarterly Revenues Feb 03 2014
Mesa Labs Declares Quarterly Dividend Jan 31 2014
MESA LABORATORIES INC /CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jan 30 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide